Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and ...

Processa Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings ...

HANOVER, Md., April 15, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next ...

Athira Pharma Inc近十二个月的ebitda-95.805百万 December 2020至2024的财年Athira Pharma Inc的ebitda为 -79.727百万 December 2020至 2024的财年，Athira Pharma Inc的ebitda中值为-93.171百万。 过去5年，Athira Pharma Inc的ebitda在December 2020 ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...